Navigation Links
Monogram Energy, Inc. Acquires Triad Therapeutics, Inc.
Date:11/19/2009

FAIRFIELD, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Monogram Energy, Inc. ("Monogram") (Pink Sheets: MGRN) announced today that it had completed the acquisition of Triad Therapeutics, Inc. ("Triad"), which was effective as of October 30, 2009. Under the terms of the Stock Purchase and Recapitalization Agreement, shareholders of Monogram acquired 100% of the outstanding shares of Triad in exchange for approximately 95% ownership to the Triad shareholders in the combined company. Monogram intends to apply to FINRA to change their name to Triad Therapeutics Holdings, Inc. and obtain a new ticker symbol.

Triad Therapeutics, a Joint Commission (JCAHO) accredited company, provides complex intravenous pharmaceuticals and supplies along with clinical nursing/pharmacy services to patients at home and in alternate care facilities. The specialized IV infusion services involve the administration of compounded medications needed in the treatment of a wide range of acute and chronic conditions including; infectious diseases, intractable pain, cardiovascular disease, multiple sclerosis and other neuromuscular disorders, nutritional disorders, and auto-immune diseases, dehydration, and IV catheter insertions with routine maintenance. The therapies associated with these conditions do not fit into the retail drug distribution model due to cost and the need for specialized pharmaceutical compounding, handling, and the need for extensive patient training by IV certified nursing professionals.

Forward-Looking Statements:

The statements which are not historical facts contained in this release are forward-looking statements that involve risks and uncertainties, including but not limited to, the effect of economic conditions, the impact of competition, the results of financing efforts, changes in consumers' preferences and trends. The words "estimate," "possible," and "seeking" and similar expressions identify forward-looking statements, which speak only to the date the statement was made. The Company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events, or otherwise. Future events and actual results may differ materially from those set forth herein, contemplated by, or underlying the forward-looking statements.

SOURCE Monogram Energy, Inc.


'/>"/>
SOURCE Monogram Energy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Monogram Announces First Medicare Payment for Trofile(TM)
2. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
3. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
4. Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
5. Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
6. Monogram Announces 2008 Second Quarter Financial Results
7. Reliant Energy, Houston Texans Ahman Green and Matt Schaub Team to Hold News Conference, Book Signing to Raise Awareness about Autism
8. Study names 5 factors of social ills in energy, mining and logging communities
9. Healthcare and Education Building Markets Remain Particularly Strong as Energy, Materials and Commodity Costs Drive Construction Pricing Upward
10. DC policy panels on energy, environment, health care, aviation precede November election
11. Pennsylvania Governor Rendell Highlights Renewable Energy, Health Care Reform at Ag Progress Days
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... ... FCPX LUT Vintage Volume 2 for Final Cut Pro X allows users ... contains 60 different color-grade presets, giving editors multiple options for adding different color options. ... subjects, plus much more. FCPX LUT Vintage Volume 2 is designed for any skill-set ...
(Date:6/25/2017)... , ... June 25, 2017 , ... Republicans in the ... and replace Obamacare, called the Better Care Reconciliation Act. It differs significantly from the ... will need to be reconciled in committee, or the House will have to take ...
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the Root ... Orleans. This is a new, greatly improved version of the Doctor Referral teaming dataset ... by Fred Trotter and subsequently called the the “Doctor Referral Dataset” as released by ...
(Date:6/25/2017)... ... ... and the focus is on prostate cancer. Second only to skin cancer, prostate cancer ... cause of cancer related death today; lung cancer remains in the number one spot. Currently ... his lifetime. Those at highest risk are men who have a family history ...
(Date:6/24/2017)... ... 24, 2017 , ... The Pennsylvania Athletic Trainers’ Society’s (PATS) ... Erie Convention Center on June 8-10. The weekend consisted of many educational ... and scholarship presentations, and professional networking. , On Friday June 9th, PATS ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... June 9, 2017 AirXpanders, Inc. (ASX: AXP) ... the design, manufacture, sale and distribution of the AeroForm® ... progress of its commercial roll-out in the ... more than one hundred (100) medical institutions and health ... offers a needle-free alternative for women who choose reconstructive ...
(Date:6/7/2017)... 7, 2017 Endo International plc (NASDAQ: ... the Hon. Joseph R. Goodwin , U.S. District ... West Virginia , entered a case management order ... System Products Liability Litigation (the "MDL") that includes a ... provide expert disclosures on specific causation within one hundred ...
(Date:6/3/2017)... INDIANAPOLIS , June 3, 2017  Eli ... today announced that results from the Phase 3 ... kinase (CDK)4 & 6 inhibitor, in combination with ... treatment with fulvestrant alone in women with hormone-receptor-positive ... advanced breast cancer who have relapsed or progressed ...
Breaking Medicine Technology: